奥美医疗(002950.SZ)：2025年中报净利润为2.00亿元

Core Insights - The company, Aomei Medical (002950.SZ), reported a total revenue of 1.676 billion yuan and a net profit attributable to shareholders of 200 million yuan for the first half of 2025 [1] - The operating cash flow was 345 million yuan, indicating a positive cash flow situation [1] Financial Performance - The latest debt-to-asset ratio stands at 28.48%, ranking 51st among disclosed peers [3] - The gross profit margin is 29.64%, which is a decrease of 0.88 percentage points from the previous quarter, ranking 64th among peers [3] - The return on equity (ROE) is 5.58%, down by 0.17 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.32 yuan [3] - The total asset turnover ratio is 0.33 times, while the inventory turnover ratio is 2.05 times [3] Shareholder Structure - The number of shareholders is 37,500, with the top ten shareholders holding a total of 424 million shares, accounting for 66.93% of the total share capital [4] - The largest shareholder is Cui Wenhai, holding 23.0% of the shares [4] - Other significant shareholders include Cheng Hong (15.1%), Chen Haohua (11.5%), and Wan Xiaoxiang (9.87%) [4]